Aptimmune Biologics - Ownership and Business Overview

Life ScienceCompany

Aptimmune Biologics Ownership

Who owns Aptimmune Biologics?

Aptimmune Biologics is owned by Kemin Industries. It was acquired on August 7, 2018.

Aptimmune Biologics Business Overview

Where is Aptimmune Biologics headquartered?

Aptimmune Biologics is headquartered in St. Louis, Missouri.

What sector is Aptimmune Biologics in?

Aptimmune Biologics is a life science company.

Life Science M&A Summary in 2018

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.

Join Mergr to view all 246 acquisitions of life science companies in 2018, including 44 acquisitions by private equity firms, and 202 by strategics.

Aptimmune Biologics, Inc.

1005 N. Warson Road,
St. Louis, Missouri 63132
United States,
(314) 736-4488
www.aptimmune.com

Aptimmune Biologics, Inc. is specializes in developing and marketing a portfolio of revolutionary mucosal vaccines that provide answers for the most costly viral diseases impacting the swine industry. Aptimmune Biologics is based in St. Louis, Missouri.


 Subscribe to unlock this and 209,130
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.